SHENZHEN, China , Oct. 30, 2024 /PRNewswire/ -- MGI Tech Co., Ltd.
("MGI") , a company committed to building core tools and technologies that drive innovation in life science, is thrilled to announce that its DNBSEQ-T20x2 Genetic Sequencer* has been recognized as a Special Mention in the TIME Best Inventions 2024 list. TIME Best Inventions recognizes products, software, or services that are revolutionizing the world. Curated by a network of TIME editors, the annual list recognizes inventions big and small from around the globe.
This year, the DNBSEQ-T20x2 joined the ranks of the world's most groundbreaking products, technologies, and services for its creativity, meaningful innovation, and significant impact on modern healthcare. MGI's DNBSEQ-T20x2 ultra-high-throughput sequencer has garnered prominent interest and attention since its debut in February 2023 for bringing down the cost of genome sequencing to 50,000 WGS per year for under $100 per 30x human genome. It was specifically recognized for its leading-edge applications in biotech and for laying the groundwork for more accessible and cost-effective high-throughput sequencing.
By providing scalable genome sequencing capabilities, the DNBSEQ-T20x2 enables researchers to perform large-scale genomic analyses at a reduced cost, thereby opening more doors to delivering research on precision medicine. These capabilities are especially impactful in areas where accurate and affordable sequencing can be leveraged to improve outco.